Sirolimus: all 520 studies that test it
Page 6 of 6. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell TransplantationCompletedNCT00144677Phase 2
- Efficacy and Safety of Sirolimus in Combination With TacrolimusStatus unknownNCT00141804Phase 3
- Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant RecipientsTerminatedNCT00137345Phase 3
- TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant RecipientsCompletedNCT00133887Phase 3
- Study of Unrelated Cord Blood Transplantation Using Tacrolimus and SirolimusCompletedNCT00133367Phase 2
- Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00098462Phase 1/2
- Treating Multiple Sclerosis With Sirolimus, an Immune System SuppressorTerminatedNCT00095329Phase 1/2
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00089037Phase 1/2
- Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's LymphomaTerminatedNCT00068302Phase 1
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Sirolimus Therapy for Idiopathic and Lupus Membranous NephropathyCompletedNCT00050713Phase 2
- Sirolimus in Treating Patients With Glioblastoma MultiformeCompletedNCT00047073Phase 1/2
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsCompletedNCT00044720Phase 4
- Sirolimus for Focal Segmental GlomerulosclerosisCompletedNCT00040508Phase 2
- Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant RecipientsCompletedNCT00037531Phase 3
- Steroid Withdrawal in Pediatric Kidney Transplant RecipientsTerminatedNCT00023244Phase 2
- Pediatric Kidney Transplant Without Calcineurin InhibitorsCompletedNCT00023231Not applicable
- A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney TransplantTerminatedNCT00005113Phase 3
- Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow TransplantWithdrawnNCT00002790Phase 1/2